These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6151328)

  • 21. Immunoglobulins of patients recovering from Yersinia enterocolitica infections exhibit Graves' disease-like activity in human thyroid membranes.
    Wolf MW; Misaki T; Bech K; Tvede M; Silva JE; Ingbar SH
    Thyroid; 1991; 1(4):315-20. PubMed ID: 1688156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Onset of subacute aggravation of chronic thyroiditis followed immediately by transient hypothyroidism during antithyroid drug therapy for Graves' hyperthyroidism.
    Shigemasa C; Shirota K; Urabe K; Kouchi T; Mitani Y; Ueta Y; Yoshida A; Mashiba H
    Horm Res; 1991; 35(5):208-12. PubMed ID: 1687041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
    Tamai H; Hayaki I; Kawai K; Komaki G; Matsubayashi S; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1995 May; 80(5):1481-4. PubMed ID: 7744989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease.
    Kasagi K; Tamai H; Morita T; Hidaka A; Hatabu H; Misaki T; Iida Y; Ishihara T; Ikekubo K; Kuma K
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1189-94. PubMed ID: 2566620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid stimulating antibody: an index of thyroid stimulation in Graves' disease?
    Baldet L; Madec AM; Papachristou C; Stefanutti A; Orgiazzi J; Jaffiol C
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):7-12. PubMed ID: 2889309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T4 suppression test involving 24-hour thyroidal 131I uptake in patients with Graves' disease compared to the T3 suppression test.
    Kobayashi I; Ishii H; Mori M; Kobayashi S
    Endocrinol Jpn; 1984 Jun; 31(3):263-70. PubMed ID: 6548699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum thyroid-stimulating antibody, thyroglobulin levels, and thyroid suppressibility measurement as predictors of the outcome of combined methimazole and triiodothyronine therapy in Graves' disease.
    Werner RS; Romaldini JH; Farah CS; Werner MC; Bromberg N
    Thyroid; 1991; 1(4):293-9. PubMed ID: 1688155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paired determination of thyroid-stimulating and TSH-binding inhibitory activities in patients with Graves' disease during antithyroid drug treatment.
    Kasagi K; Iida Y; Konishi J; Misaki T; Arai K; Endo K; Torizuka K; Kuma K
    Acta Endocrinol (Copenh); 1986 Apr; 111(4):474-80. PubMed ID: 2422860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.
    Teng CS; Yeung RT
    J Clin Endocrinol Metab; 1980 Jan; 50(1):144-7. PubMed ID: 6892512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
    Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
    Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient neonatal 'athyreosis' resulting from thyrotropin-binding inhibitory immunoglobulins.
    Connors MH; Styne DM
    Pediatrics; 1986 Aug; 78(2):287-90. PubMed ID: 2874542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
    Kung AW; Lau KS; Kohn LD
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in thyroid volume during antithyroid drug therapy for Graves' disease and its relationship to TSH receptor antibodies, TSH and thyroglobulin.
    Yamaguchi Y; Inukai T; Iwashita A; Nishino M; Yamaguchi T; Shohda Y; Shimomura Y; Ohshima K; Kobayashi S; Kobayashi I
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):411-5. PubMed ID: 1978459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
    Kahaly G; Grübl M; Moncayo R; Schilling S; Weber P; Beyer J; Krause U
    Dev Ophthalmol; 1989; 20():68-78. PubMed ID: 2574117
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
    Tamai H; Kasagi K; Takaichi Y; Takamatsu J; Komaki G; Matsubayashi S; Konishi J; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1989 Jul; 69(1):49-53. PubMed ID: 2471711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.